|
|
Volumn 1, Issue 2, 2003, Pages 197-202
|
|
Design of a genetically modified soybean protein preventing hypertension based on an anti-hypertensive peptide derived from ovalbumin.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE;
EGG PROTEIN;
NITRIC OXIDE;
OVALBUMIN;
OVOKININ;
PEPTIDE FRAGMENT;
SOYBEAN PROTEIN;
ANIMAL;
ARTICLE;
CHEMISTRY;
DRUG DESIGN;
DRUG EFFECT;
GENETICS;
HYPERTENSION;
METABOLISM;
RAT;
SITE DIRECTED MUTAGENESIS;
VASODILATATION;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
DRUG DESIGN;
EGG PROTEINS;
HYPERTENSION;
MUTAGENESIS, SITE-DIRECTED;
NITRIC OXIDE;
OVALBUMIN;
PEPTIDE FRAGMENTS;
PEPTIDYL-DIPEPTIDASE A;
RATS;
SOYBEAN PROTEINS;
VASODILATION;
|
|
EID: 1542323353
PISSN: 15680169
EISSN: None
Source Type: Journal
DOI: 10.2174/1568016033477496 Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
